ABVC BioPharma, Inc. (ABVC) vs Actuate Therapeutics Inc (ACTU)
A side-by-side comparison of ABVC BioPharma, Inc. and Actuate Therapeutics Inc across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ABVC
ABVC BioPharma, Inc.
$0.98HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
ACTU
Actuate Therapeutics Inc
$0.87HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — ABVC vs ACTU
growth of $100 · dividends reinvested · last 2yABVC +43.1% (+19.6%/yr)ACTU -89.8% (-68.1%/yr)ABVC compounded faster over this window
Log scale — wide-divergence pair
ABVC ACTU
ABVC vs ACTU: by the numbers
- •ABVC is the larger company ($25M vs $21M market cap).
Metrics side by side
Valuation
| Metric | ABVC | ACTU |
|---|---|---|
| P/B ratio | 2.48 | 21.16 |
Profitability
| Metric | ABVC | ACTU |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -76.82% | -2067.81% |
| ROIC | -53.34% | -1489.99% |
Growth (annualized)
| Metric | ABVC | ACTU |
|---|---|---|
| Total return CAGR (5Y) | -46.33% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.